PLAU and neoplasm: It was reported that BRMS1 suppression of tumor metastasis is mediated via inhibition of NF-kB and subsequent suppression of the urokinase-type plasminogen activator (uPA) [12], a serine protease that is known to activate the MMPs [13] leading to invasion and metastasis.